A Rehemtulla

Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy

A. Rehemtulla, D. Hamstra, LD Stegman, 2000, Gene Therapy.

The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model

Z Symon, A. Rehemtulla, Z. Symon, 2002, Gene Therapy.

Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy.

R G Blasberg, R. Blasberg, A. Rehemtulla, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts.

A. Rehemtulla, E. Bershad, T. Lawrence, 1999, Cancer research.

Combined radiation and enzyme/prodrug treatment for head and neck cancer in an orthotopic animal model.

A. Rehemtulla, D. Hamstra, A. Pu, 1999, Radiation research.

Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function.

T S Edgington, W Ruf, A. Rehemtulla, 1991, The Journal of biological chemistry.

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy.

T L Chenevert, A. Chinnaiyan, T. Chenevert, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.

A. Rehemtulla, T. Lawrence, A Rehemtulla, 2000, Cancer research.